Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISPERIDONE Cause Atrioventricular block second degree? 36 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Atrioventricular block second degree have been filed in association with RISPERIDONE (Risperidone). This represents 0.1% of all adverse event reports for RISPERIDONE.

36
Reports of Atrioventricular block second degree with RISPERIDONE
0.1%
of all RISPERIDONE reports
0
Deaths
26
Hospitalizations

How Dangerous Is Atrioventricular block second degree From RISPERIDONE?

Of the 36 reports, 26 (72.2%) required hospitalization, and 12 (33.3%) were considered life-threatening.

Is Atrioventricular block second degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 36 reports have been filed with the FAERS database.

What Other Side Effects Does RISPERIDONE Cause?

Gynaecomastia (24,453) Off label use (10,376) Abnormal weight gain (9,418) Weight increased (6,885) Emotional disorder (5,809) Product use in unapproved indication (5,551) Drug ineffective (5,232) Injury (4,447) Hyperprolactinaemia (4,124) Galactorrhoea (3,513)

What Other Drugs Cause Atrioventricular block second degree?

FINGOLIMOD (167) DILTIAZEM (76) BISOPROLOL (73) METOPROLOL (67) OMEPRAZOLE (64) AMLODIPINE (58) ASPIRIN (55) LACOSAMIDE (55) AMIODARONE (49) FLUOXETINE (44)

Which RISPERIDONE Alternatives Have Lower Atrioventricular block second degree Risk?

RISPERIDONE vs RITALIN RISPERIDONE vs RITLECITINIB RISPERIDONE vs RITODRINE RISPERIDONE vs RITONAVIR RISPERIDONE vs RITUXAN

Related Pages

RISPERIDONE Full Profile All Atrioventricular block second degree Reports All Drugs Causing Atrioventricular block second degree RISPERIDONE Demographics